Analyze Diet
Equine veterinary journal1999; 31(6); 473-477; doi: 10.1111/j.2042-3306.1999.tb03853.x

A serological and clinical follow-up in horses with confirmed equine granulocytic ehrlichiosis.

Abstract: For diagnosis of equine granulocytic ehrlichiosis (EGE) serological testing of antibodies to Ehrlichia equi is frequently used. An elevated antibody level is often misinterpreted as confirmative of active infection and results in treatment with antibiotics. If only seropositivity is considered as the diagnostic criterium, many horses showing convalescence titres will be treated. This study was undertaken to obtain information about the kinetics of antibodies during the course of infection and, for this purpose, 45 horses with clinical signs of EGE and confirmed ehrlichiaemia were monitored serologically and clinically over time. For a correct handling of cases with suspected EGE, the following results should be helpful: (i) 44% of the horses in the acute ehrlichiaemic stage were found to be serologically positive to E. equi; (ii) all horses showed a rapid increase in antibody titre, reaching maximum value within a month after the ehrlichiaemic stage; (iii) when 8 months had passed, titres had decreased, but 18 of 24 examined horses were still serologically positive; (iv) after 12-15 months most of the horses (n = 10) were serologically negative; and (v) the period required for complete clinical recovery varied from one day up to 6 months after antibiotic treatment.
Publication Date: 1999-12-22 PubMed ID: 10596927DOI: 10.1111/j.2042-3306.1999.tb03853.xGoogle Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research investigated the kinetics of antibodies in horses with equine granulocytic ehrlichiosis (EGE), a disease infecting white blood cells, to correct common misinterpretations on elevated antibody level as confirmation of active infection.

Research Objective

  • This study was undertaken to understand the behavior and movement of antibodies during the course of EGE, a disease that often leads to incorrect treatment of horses based on misinterpretations of elevated antibody levels as active infection. It focused on the period within which the antibody levels peak and decline, and the time it takes for clinical recovery after treatment.

Methods and Participants

  • 45 horses with EGE and confirmed ehrlichiaemia, a condition characterized by bacterium Ehrlichia in the blood, were observed in this study. The horses were monitored both serologically (concerning the serum or plasma in blood) and clinically over a period.

Findings

  • It was found that only 44% of the horses in the acute ehrlichiaemic stage were serologically positive for E. equi, the bacterium causing EGE.
  • All the horses demonstrated a rapid increase in antibody titre, achieving its highest value within a month after entering the ehrlichiaemic stage.
  • When eight months had passed, the antibody levels decreased, but almost 75% of examined horses (18 out of 24) were still serologically positive.
  • After a period of 12-15 months, most horses tested (10 out of a non-specified amount) were found to be serologically negative.
  • The time frame for complete clinical recovery after antibiotic treatment varied from just a single day up to as long as six months.

Conclusion

  • This study provided valuable insights into the kinetics of antibodies during EGE, which can help in diagnosing and treating the disease more accurately. The research concluded that elevated antibody levels should not always be considered as an indication of active infection, and that the period of clinical recovery post-antibiotic treatment can significantly vary.

Cite This Article

APA
Artursson K, Gunnarsson A, Wikström UB, Engvall EO. (1999). A serological and clinical follow-up in horses with confirmed equine granulocytic ehrlichiosis. Equine Vet J, 31(6), 473-477. https://doi.org/10.1111/j.2042-3306.1999.tb03853.x

Publication

ISSN: 0425-1644
NlmUniqueID: 0173320
Country: United States
Language: English
Volume: 31
Issue: 6
Pages: 473-477

Researcher Affiliations

Artursson, K
  • Department of Bacteriology, The National Veterinary Institute, Uppsala, Sweden.
Gunnarsson, A
    Wikström, U B
      Engvall, E O

        MeSH Terms

        • Animals
        • Antibodies, Bacterial / blood
        • Ehrlichia / immunology
        • Ehrlichiosis / blood
        • Ehrlichiosis / immunology
        • Ehrlichiosis / veterinary
        • Female
        • Follow-Up Studies
        • Granulocytes
        • Horse Diseases / blood
        • Horse Diseases / immunology
        • Horses
        • Male
        • Polymerase Chain Reaction / veterinary

        Citations

        This article has been cited 20 times.
        1. Rule EK, Boyle AG, Stefanovski D, Anis E, Linton J, Lorello O. Transfer of naturally acquired specific passive immunity against Anaplasma phagocytophilum in foals in Southeastern Pennsylvania and Northern Maryland.. J Vet Intern Med 2023 Sep-Oct;37(5):1889-1892.
          doi: 10.1111/jvim.16812pubmed: 37515307google scholar: lookup
        2. Grandi G, Aspán A, Pihl J, Gustafsson K, Engström F, Jinnerot T, Söderlund R, Chirico J. Detection of Tick-Borne Pathogens in Lambs Undergoing Prophylactic Treatment Against Ticks on Two Swedish Farms.. Front Vet Sci 2018;5:72.
          doi: 10.3389/fvets.2018.00072pubmed: 29713635google scholar: lookup
        3. Stuen S, Okstad W, Sagen AM. Intrauterine Transmission of Anaplasma phagocytophilum in Persistently Infected Lambs.. Vet Sci 2018 Feb 28;5(1).
          doi: 10.3390/vetsci5010025pubmed: 29495651google scholar: lookup
        4. Tinkler SH, Firshman AM, Sharkey LC. Premature parturition, edema, and ascites in an alpaca infected with Anaplasma phagocytophilum.. Can Vet J 2012 Nov;53(11):1199-202.
          pubmed: 23633715
        5. Brown WC. Adaptive immunity to Anaplasma pathogens and immune dysregulation: implications for bacterial persistence.. Comp Immunol Microbiol Infect Dis 2012 May;35(3):241-52.
          doi: 10.1016/j.cimid.2011.12.002pubmed: 22226382google scholar: lookup
        6. Uehlinger FD, Clancey NP, Lofstedt J. Granulocytic anaplasmosis in a horse from Nova Scotia caused by infection with Anaplasma phagocytophilum.. Can Vet J 2011 May;52(5):537-40.
          pubmed: 22043078
        7. Grøva L, Olesen I, Steinshamn H, Stuen S. Prevalence of Anaplasma phagocytophilum infection and effect on lamb growth.. Acta Vet Scand 2011 May 13;53(1):30.
          doi: 10.1186/1751-0147-53-30pubmed: 21569524google scholar: lookup
        8. Stuen S, Grøva L, Granquist EG, Sandstedt K, Olesen I, Steinshamn H. A comparative study of clinical manifestations, haematological and serological responses after experimental infection with Anaplasma phagocytophilum in two Norwegian sheep breeds.. Acta Vet Scand 2011 Feb 11;53(1):8.
          doi: 10.1186/1751-0147-53-8pubmed: 21314927google scholar: lookup
        9. Hansson-Hamlin H, Lilliehöök I. A possible systemic rheumatic disorder in the Nova Scotia duck tolling retriever.. Acta Vet Scand 2009 Mar 30;51(1):16.
          doi: 10.1186/1751-0147-51-16pubmed: 19331658google scholar: lookup
        10. Stuen S, Dahl H, Bergström K, Moum T. Unidirectional suppression of Anaplasma phagocytophilum genotypes in infected lambs.. Clin Diagn Lab Immunol 2005 Dec;12(12):1448-50.
        11. Stuen S, Oppegaard AS, Bergström K, Moum T. Anaplasma phagocytophilum infection in north Norway. The first laboratory confirmed case.. Acta Vet Scand 2005;46(3):167-71.
          doi: 10.1186/1751-0147-46-167pubmed: 16261930google scholar: lookup
        12. Stuen S, Bergström K, Palmér E. Reduced weight gain due to subclinical Anaplasma phagocytophilum (formerly Ehrlichia phagocytophila) infection.. Exp Appl Acarol 2002;28(1-4):209-15.
          doi: 10.1023/a:1025350517733pubmed: 14570133google scholar: lookup
        13. Stuen S, Bergström K, Petrovec M, Van de Pol I, Schouls LM. Differences in clinical manifestations and hematological and serological responses after experimental infection with genetic variants of Anaplasma phagocytophilum in sheep.. Clin Diagn Lab Immunol 2003 Jul;10(4):692-5.
        14. Stuen S, Van De Pol I, Bergström K, Schouls LM. Identification of Anaplasma phagocytophila (formerly Ehrlichia phagocytophila) variants in blood from sheep in Norway.. J Clin Microbiol 2002 Sep;40(9):3192-7.
        15. Stuen S, Bergström K. Persistence of Ehrlichia phagocytophila infection in two age groups of lambs.. Acta Vet Scand 2001;42(4):453-8.
          doi: 10.1186/1751-0147-42-453pubmed: 11957373google scholar: lookup
        16. Stuen S, Djuve R, Bergström K. Persistence of granulocytic Ehrlichia infection during wintertime in two sheep flocks in Norway.. Acta Vet Scand 2001;42(3):347-53.
          doi: 10.1186/1751-0147-42-347pubmed: 11887395google scholar: lookup
        17. Stuen S, Bergström K. The effect of two different oxytetracycline treatments in experimental Ehrlichia phagocytophila infected lambs.. Acta Vet Scand 2001;42(3):339-46.
          doi: 10.1186/1751-0147-42-339pubmed: 11887394google scholar: lookup
        18. Stuen S, Bergström K. Serological investigation of granulocytic Ehrlichia infection in sheep in Norway.. Acta Vet Scand 2001;42(3):331-8.
          doi: 10.1186/1751-0147-42-331pubmed: 11887393google scholar: lookup
        19. Stuen S, Engvall EO, Brändström B, Slettebø J. A case of ovine tick-borne fever in December in Norway.. Acta Vet Scand 1999;40(4):351-4.
          doi: 10.1186/BF03547014pubmed: 10918904google scholar: lookup
        20. Stuen S, Artursson K, Olsson Engvall E. Experimental infection of lambs with an equine granulocytic Ehrlichia species resembling the agent that causes human granulocytic ehrlichiosis (HGE).. Acta Vet Scand 1998;39(4):491-7.
          doi: 10.1186/BF03547775pubmed: 9926463google scholar: lookup